SAN FRANCISCO, Aug 22 (Reuters) - Genentech Inc is on the hunt for partnerships and investment opportunities in medical-technology startups, Chief Executive Officer Ian Clark told Reuters, underscoring the industry's growing interest in digital ... CNBC, 15 hours ago
Genentech hunting Silicon Valley startups, technology - Yahoo! UK and Ireland, 14 hours ago
SAN FRANCISCO — With the arrival of consumer-driven health care, more people will have access to their own genome as a way of guiding the management of their physical well-being. But this has adownside, as 23andMe's run-in with the FDA last ...MedCity News, 23 hours ago Genentech CEO: FDA needs more funding to review genome products Venturebeat, 1 day ago
By , editor, Pharmaceutical Online and Bioresearch Online Follow Me On Twitter @pharmaonline and @bioresearchonline Quality by Design is a term that ignites both excitement and apprehension among those in the pharmaceutical manufacturing and ...Pharmaceutical Online, 1 day ago
(TOSHIBA/AFP/) Some health industry observers think wearables that measure users biometrics are the next big thing in health care. Genentech's CEO is more skeptical. I do wonder about wearables, Ian Clark told Re/code co-founder Kara Swisher ...San Francisco Chronicle, 1 day ago
Genentech reported that the U.S. Food and Drug Administration (FDA) approved Avastin (bevacizumab) in combination with paclitaxel and cisplatin or paclitaxel and topotecan for the treatment of women with persistent, recurrent or metastatic carcinoma ...Individual.com, 4 days ago Genentech Turns in Supplemental Biologics License Application [Professional Services Close - Up] Pharmacy Choice, 4 days ago FDA approves Avastin plus chemotherapy to treat advanced cervical cancer European Pharmaceutical Manufacturer, 1 day ago ROCHE BEARER SHARE : FDA OKs Genentech's Avastin Plus Chemotherapy for Treatment of Advanced Cervical Cancer 4 Traders, 2 days ago
NEW DATA FROM GENENTECH, INC. ILLUMINATE FINDINGS IN ONCOLOGY RESEARCH (HGF/MET-DIRECTED THERAPEUTICS IN GASTROESOPHAGEAL CANCER : a review of...
New Data from Genentech, Inc. Illuminate Findings in Oncology Research (HGF/MET-directed therapeutics in gastroesophageal cancer: a review of clinical and biomarker development) By a News Reporter-Staff News Editor at Cancer Weekly -- ...4 Traders, 2 days ago Researchers from Genentech, Inc. Provide Details of New Studies and Findings in the Area of Graft-Versus-Host Disease (Administration of Anti-CD20... 4 Traders, 2 days ago
Investigators from Genentech, Inc. Release New Data on Arthritis (PILR alpha Negatively Regulates Mouse Inflammatory Arthritis)
By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on Joint Diseases and Conditions is now available. According to news reporting originating in San Francisco, California , by NewsRx journalists, research stated, "Paired ...4 Traders, 1 week ago Mylan unveils generic version of Genentech's Xeloda for breast and colon cancers MedCity News, 1 week ago Mylan Launches Generic Xeloda® Tablets 4 Traders, 2 days ago Mylan Launches Generic Precedex Sedative as Hospira Sues FDA Pharmacy Times, 3 days ago
New Findings from Genentech in the Area of Apoptosis Reported (Cell death. Opposing unfolded-protein-response signals converge on death receptor 5 to...
New Findings from Genentech in the Area of Apoptosis Reported (Cell death. Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis) By a News Reporter-Staff News Editor at Health & Medicine Week -- Research ...4 Traders, 1 week ago
WASHINGTON , Aug. 22 -- The Blinded Veterans Association issued the following news release: Fourteen U.S. combat-blinded service members injured in Iraq , Afghanistan , and Operation Desert Storm joined seven British legally blind veterans at the ...HispanicBusiness.com, 3 hours ago
PR Newswire CHAPEL HILL, N.C., Aug. 22, 2014 CHAPEL HILL, N.C. , Aug. 22, 2014 /PRNewswire/ --As the Medical Affairs' role has become more important in the healthcare sector, many leaders in this area are exploring methods to develop ...Reuters, 16 hours ago
on your WebpageAdd Widget >Get your members hooked!